Philips Respironics and Philips subsidiaries in the U.S. received the subpoena on April 8 seeking “information related to events leading to the Respironics recall,” the Amsterdam-based company said as it announced its latest financial and operating results. Phillips said its subsidiaries are cooperating with investigators.
“At this time, it’s a subpoena for information,” CEO Frans van Houten said on today’s earnings call. “That means they are preparing an investigation, and we just have to accept that.”
Philips shares dropped about 12% in trading Monday as the company detailed continued supply chain struggles and mounting recall costs.
Van Houten said Phillips remains in close collaboration and contact with regulatory agencies.…